All vaccines provided to beneficiaries at the government health facilities will be entirely free of cost, while private facilities cannot charge the beneficiary a sum above Rs 250 per person per dose

The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states

In the second phase of COVID-19 vaccination drive in India, people above 60 years and above 45 years with comorbidities would be administered the vaccine at 10,000 government medical facilities and over 20,000 private hospitals

The option to reduce waiting period existed earlier also in some health plans, but what has changed now is the affordability factor and relaxed underwriting norms.

Stocks to watch today on January 20: Tata Communications, Sterlite Tech, Sun Pharma, Ceat, L&T Infotech among others are the top stocks to watch out for in Wednesday's trading session

The two vaccines - Covishield and Covaxin - have received regulatory approval after extensive studies. The Covishield  vaccine has already been rolled out in the UK

Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks

The human cost and the price for not addressing adequately the topic of obesity & diabetes is very high. Also, it impairs our social development as well as reduced economic development potential. It's time to wake up and smell the coffee, but of course, without the sugar

According to researchers from Brigham and Women's Hospital in the US, the condition known as diabetic ketoacidosis (DKA), can arise when illness prevents cells from receiving enough glucose to fuel their functioning

COVID-19 vaccine will be introduced only when the safety is proven. As is true for other vaccines, the common side effects in some individuals could be mild fever, pain, etc. at the site of injection, said the ministry

Dr Randeep Guleria, the head of All India Institute of Medical Sciences (AIIMS), is reportedly heading the team that's preparing the list of patients.

Counsellor in India's Permanent Mission to the UN Pratik Mathur stressed that nations must address all barriers against access to medicines and new technologies

Stocks to watch today on December 1: ICICI Lombard, Unichem Labs, Indiabulls Housing, Tata Motors, Hero MotoCorp, Dr Reddy among others are the top stocks to watch out for in Tuesday's trading session

With more than 50,000 centres having been established, one-third of the target has been met

While comprehensive policies also cover diabetes in India, they come with a long waiting period and may not be available to a patient during an acute phase of it. These people can go for diabetic specific plans

R Rajhans' son, Siddharth, moved by what the Apple Watch did for his father, wrote to Craig Federighi, Senior Vice President of software engineering at Apple, and thanked him

Coronavirus impact: The report said that the treatment could only partially improve the UK patient's impairment. It must be mentioned here that the \"rapid and unexplained\" deafness apparently only affects one ear

While insurers now see the physical and mental diseases from the same prism, the treatment of former is quite different from the latter

The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations

The researchers, including those from Norfolk and Norwich University Hospital, analysed what the impact of these medications is for people with COVID-19